Objective: Reanimation of muscles paralyzed by disease states such as spinal cord injury remains a 14 much sought after therapeutic goal of neuroprosthetic research. Optogenetic stimulation of 15 peripheral motor nerves expressing light-sensitive opsins is a promising approach to muscle 16 reanimation that may overcome several drawbacks of traditional methods such as functional 17 electrical stimulation (FES). However, the utility of these methods has only been demonstrated in 18 rodents to date, while translation to clinical practice will likely first require demonstration and 19 refinement of these gene therapy techniques in non-human primates. 20
21 optogenetic constructs (AAV6-hSyn-ChR2-eYFP and/or AAV6-hSyn-Chronos-eYFP) to transduce 22 opsin expression in the corresponding nerves. Neuromuscular junctions were targeted for virus 23 delivery using an electrical stimulating injection technique. Functional opsin expression was 24 periodically evaluated up to 13 weeks post-injection by optically stimulating targeted nerves with a 25 472 nm fiber-coupled laser while recording electromyographic (EMG) responses. 26
Main Results: One monkey demonstrated functional expression of ChR2 at 8 weeks post-injection in 27 each of two injected muscles, while the second monkey briefly exhibited contractions coupled to 28 optical stimulation in a muscle injected with the Chronos construct at 10 weeks. A third monkey 29 injected only in one muscle with the ChR2 construct showed strong optically coupled contractions at 30 5 ½ weeks which then disappeared by 9 weeks. EMG responses to optical stimulation of ChR2-31 transduced nerves demonstrated graded recruitment relative to both stimulus pulse-width and light 32 intensity, and were able to track stimulus trains up to 16 Hz. In addition, the EMG response to 33 prolonged stimulation showed delayed fatigue over several minutes. 34 This scheme allowed the subject to reclaim certain daily functions such as feeding himself, but these 63 movements were quite slow, taking several tens of seconds for tasks that most people would 64 complete in a second or two. FES-mediated movements in this study also required additional 65 hardware to support the arm against gravity. These studies demonstrate that the current state-of-the 66 art for muscle stimulation necessitates major technological advances to approach practical relevance 67 or even approach the performance level of other BMI-driven effectors such as robotic arms. 68
The difficulties highlighted by this study may be due to several inherent drawbacks of FES. 69 For example, electrical stimulation of muscle activity often leads to non-physiological recruitment of 70 muscle fibers. Under normal physiological activation, small, fatigue-resistant muscle fibers are 71 recruited first at low activation levels followed by increasing recruitment of larger, fatigue-prone 72 fibers at higher activation levels. In addition, the muscle fibers are often recruited in a random or 73 reverse order (large fibers first followed by small) compared to physiological activation (small to 74 large) (Henneman, 1957 
Virus injections 187
Aseptic techniques were used for all virus injection surgeries. Prior to virus injection, each monkey 188 was sedated with a cocktail of ketamine (20 mg/kg) and xylazine (0.5 mg/kg). For each target 189 muscle, a skin incision was made to expose the muscle while leaving the surrounding fascia intact.
190
Following virus injection procedures as described below, all skin incisions were closed with 191 subcuticular stitches. Injected animals received a 5 day course of antibiotics and were returned to 192 their home cage to recover for at least three weeks before evaluation expression. Model 2200). As electrical stimulation was applied, the needle was slowly advanced into the muscle 208 by hand while monitoring muscle twitches. After finding a needle insertion position facilitating 209 maximum contraction, stimulation was paused and 200 µL of virus were injected over approximately 210 1 minute. The needle was held in place for an additional minute before slowly withdrawing it. This 211 process was repeated for each injection site. Injections were aimed at the presumed line of 212 neuromuscular junctions approximately 1/3 of the muscle length away from the proximal end of the 213 muscle. Needle insertions were aimed in both proximal-to-distal and distal-to-proximal fashions 214 toward this zone, and were spaced laterally across the muscle surface. 215
Monkey O received injections of both the ChR2 and Chronos viral constructs. Four muscles groups 216 (two flexor/extensor pairs) were targeted. In the right leg, we injected TA muscle with the AAV6-217 hSyn-ChR2-eYFP construct, and we injected the lateral gastrocnemius (GN) with AAV6-hSyn-218
Chronos-eYFP. In the left forearm, we injected the extensor digitorum (ED) with the ChR2 219 construct, and we injected both flexor carpi radialis (FCR) and pronator teres (PT) muscles with the 220
Chronos solution. For each muscle, 100 µL of stock virus was diluted with hypertonic saline to 2 mL 221 total volume (5.02x10 12 vp/mL for ChR2, 5.0x10 12 vp/mL for Chronos). The Chronos solution was 222 split evenly between the FCR and PT muscles in the forearm. Targeting of the muscle endplates and 223 muscle injections were performed in a similar fashion to those described for Monkey M. 224
Monkey P was injected with the AAV6-ChR2 construct in the right TA muscle. 100 µL of stock 225 virus (1.04x10 13 vp) was diluted to a total volume of 1 mL with hypertonic saline at a slightly higher 226 concentration (1.04x10 13 vp/mL) than the highest used used in Monkey M. Stimulating injections 227 targeting neuromuscular junctions were used to deliver 900 µL of virus solution to the muscle over 5 228 sites. The deep peroneal (DP) nerve innervating the TA muscle was also exposed near its insertion 229 into the TA via blunt separation of fibers of the overlying biceps femoris muscle. 100 µL of virus 230 solution was injected directly into the DP nerve over 3 sites. 231
Expression evaluation 232
Each monkey was periodically evaluated for opsin expression over the course of 8-13 weeks. During 233 an evaluation surgery, the monkey was anesthetized, and a previously injected muscle was re-234 exposed. Blunt dissection was used to separate fascia from the muscle and to expose the innervating 235 nerve. Electrical stimulation of the nerve using a pair of bipolar hook electrodes (Cadwell 236
Laboratories, Kennewick, WA) was used to confirm the identity of the desired nerve. Optical 237 stimulation was delivered using a 400 µm diameter core multimode fiber (ThorLabs, Newton, NJ) 238 connected to a 150 mW, 472 nm fiber-coupled laser (LaserGlow Technologies, Toronto, Ontario). 239
Maximum laser output at the fiber tip was typically around 110 mW. While moving the fiber tip 240 manually along the length of the nerve, optical stimulation trains of 15-20 ms pulses at 2.5 Hz and 241 100 mW were delivered to scan the nerve for areas sensitive to optical stimulation. A pair of the 242 injectable electrode needles (same model as used for stimulation during muscle injection) was 243 inserted into the muscle belly to measure EMG activity with a metal hub needle in the skin edge 244 serving as electrical ground. EMG electrodes were connected to a low-impedance differential 245 headstage with 20x gain (RA16LI-D, Tucker Davis Technologies (TDT), Alachua, FL). A TDT 246 neurophysiology recording system (RZ-2) was used to coordinate optical stimulation waveforms with 247 EMG recordings. All waveforms were sampled at 24 kHz. 248
Following periodic evaluations of nerve expression, any retracted muscle and fascia overlying target 249 nerves were sutured in layers with absorbable suture. Skin incisions were closed with subcuticular 250 stitches, and the animal was returned to his cage to recover. 251
Perfusion, tissue clearing, and imaging 252
Following final evaluation of opsin expression, each animal was perfused transcardially with 1X 253 phosphate buffer solution (PBS) followed by 4% paraformaldehyde (PFA). Sections of targeted 254 nerves were harvested and post-fixed in 4% PFA overnight, after which they were stored in 0.02% 255 sodium azide solution in PBS at 4° C while awaiting processing for tissue clearing. Several nerve 256 samples from each animal were reserved for tissue clearing and whole sample imaging. 5-10 mm 257 long sections of nerve were excised from the main nerve branch directly innervating virus targeted 258 muscles. Nerve samples were cleared using the polyethylene glycol (PEG)-associated solvent system 259 (PEGASOS) passive immersion protocol (Jing et al., 2018 by applying a gaussian filter with a standard deviation of 6 and then a morphologic opening with a 279 disk structuring element of radius 200 pixels. A flattening filter was produced by taking the mean of 280 the background filter divided by the background filter: 281
First the flattening filter was applied to both the RAW image and the background filter by 282 multiplying the two images. The flattened background filter was subtracted from the resulting 283 image: 284
Flattened and background-subtracted images were then assembled into volumes using the Imaris File 285
Converter and analyzed using Imaris v9.2.1 (Bitplane). Models of eYFP expressing nerve axon 286 segments were built using the Imaris Surpass surface tool. initial placement of the cuff, the nerve no longer initiated PT contractions when stimulated with blue 318 light from the cuff or optical fiber. We suspected the nerve may have become irritated by prolonged 319 exposure or irritation during the LED cuff placement, so we removed the cuff, re-sutured all nerve 320 and muscle exposures, and returned the monkey to its home cage. At 13 weeks, we re-tested each 321 targeted nerve. During this experiment, no nerves (including the previously sensitive branch to the 322 PT muscle) exhibited optical sensitivity. Electrical stimulation of the PT muscle's nerve elicited 323 brisk contractions, suggesting the nerve's health was intact. 324
The DP nerve of Monkey P innervating the injected right TA muscle was tested at 5 ½ weeks and 9 325 weeks post-injection. At the first checkpoint, optical stimulation of the exposed nerve resulted in 326 small contractions visible through the skin. Optical sensitivity was more consistent along the 327 exposed portion of the nerve than in Monkeys M and O with no obvious insensitive portions of 328 nerve. After returning to check the nerve at the 9 week time point, no visual or EMG evidence of 329 sensitivity to optical stimulation of the target nerve was present. 330
Visually observed responses to optical stimulation 331
Visible contractions to optical stimulation of targeted nerves were observed in all three monkeys. In 332 monkey M, contractions of the TA muscle were clearly visible in both legs. Additionally, 333
contractions of different portions of the muscle could be observed when different fascicles were 334 stimulated at the branch-out location of the nerve near insertion into the muscle. However, even at 335 full power stimulation (>100 mW, 30 ms pulse duration), optical stimulation along the nerve did not 336 produce functional movement of the lower leg (i.e. dorsiflexion of the foot). For the short period of 337 time that we observed optical sensitivity in monkey O, optical stimulation of a branch of the median 338 nerve produced brisk contractions of the PT muscle similar to those observed in monkey M. Again, 339 although clearly visible, these contractions did not result in pronation of the forearm. Finally, optical 340 stimulation of the right DP nerve in Monkey P resulted in contractions of the TA that could be seen 341 through the skin before further exposing the muscle belly. 342
As a set of visual checks that opsin expression was limited to nerve tissue innervating the target 343 muscle, no muscle contractions were observed when the injected muscle was directly stimulated with 344 blue light. In addition, optical stimulation of nearby non-injected muscles and their corresponding 345 nerves did not induce visible contractions or EMG activity. 346
Individual optical pulses elicit graded EMG responses to pulse duration and intensity 347
After observing visual responses to optical stimulation in monkey M, we recorded the EMG response 348 of each TA muscle to variations in several optical stimulation parameters. First, the pulse duration 349 was varied from 1 to 30 ms (100 mW). The delay from the onset of the optical pulse to a deflection 350 in EMG activity was consistent across muscles at approximately 12 ms. As shown in Figure 2A , the 351 length of the evoked EMG waveform stays relatively constant while the peak amplitude and RMS 352 increase gradually with pulse duration until plateauing at pulse durations above 10 ms as shown in 353 Figure 2B . We then measured the evoked EMG activity as a function of the incident intensity of 354 optical stimulation. Figure 2D optogenetic stimulation offers graded recruitment of muscle activity. 360
As we injected each TA muscle in monkey M with different viral loads approximately an order of 361 magnitude apart (1.66x10 13 vp in the right TA vs. 2.08x10 12 vp in the left TA), we examined whether 362 viral load impacted viral transduction and optically elicited muscle activity. We compared the EMG 363 RMS activity in each leg elicited by similar trains (20 ms pulses, 100 mW, 2.5 Hz). Although visual 364 observation did not suggest distinct differences in the magnitude of muscle contractions, the EMG 365 recorded from each leg showed appreciable differences in the shape and duration of the stimulus-366 averaged waveform. The right TA demonstrated a sharp, transient spike lasting less than 100 ms 367 (Figure 2A ) while the left TA demonstrated a waveform lasting 250 ms ( Figure 2B ). 368
Counterintuitive to the trend expected with respect to viral load, these waveforms correspond to 369
EMG RMS values of 0.027 mV and 0.051 mV, respectively. As we observed above that optical 370 sensitivity was not consistent along a nerve, these differences could arise due to the accessibility of 371 labeled fibers at a given location as opposed to the total number of transduced nerve fibers. In 372 general, however, the range of viral loads injected in this study did not appear to directly correlate 373 with differences in optically stimulated EMG activity. 374
EMG response to optical pulse trains 375
After measuring basic EMG responses of optogenetically labeled nerves to single pulses of varying 376 duration and intensity, we then examined the response to longer trains. EMG activity was measured 377 over 10 second blocks of continuous stimulation (20 ms, 100 mW) at increasing pulse frequencies 378 from 2-30 Hz. The train of responses within a frequency block (RMS value of 600 ms window 379 following onset of light pulse) was then normalized to the response of the block's first stimulus pulse 380 to assess how well the nerve and corresponding muscle activation could track the optical stimulus. 381
As shown in Figure 3, 
EMG shows delayed decay with prolonged optical stimulation 391
Finally, we assessed for any decay in optical sensitivity following optical stimulation in a transduced 392 nerve in Monkey M. The right DP nerve was stimulated continuously via the blue laser at maximum 393 power with a 10 Hz, 20 ms optical pulse train for 2 minutes. Figure 4 depicts the raw EMG trace 394 from monkey M's right TA muscle as well as the normalized RMS response to stimulation over time. 395
The normalized response falls to 70% of maximum within a few seconds and then levels off similar 396 to the 8 Hz trace in Figure 3 . However, after 40 seconds, the muscle response again trends gradually 397 downward over the next 80 seconds before approaching 40% of the initial EMG RMS response at the 398 end of stimulation. Optical stimulation of the right DP nerve of Monkey P showed a similar profile 399
with an initial drop in EMG rms after the initial few pulses followed by a sustained, consistent EMG 400 activity for the rest of the 2 minutes (see Supplementary Figure S1d ). The slow decline observed in 401 this study is again consistent with the delayed time course of muscle fatigue with optical stimulation 402 observed in rodent studies (Llewellyn et al., 2010) . 403
Whole tissue imaging demonstrates variable opsin expression 404
After final evaluation of functional expression, nerve samples were harvested, cleared, and imaged as 405 whole samples using ribbon confocal microscopy to examine opsin expression patterns. Figure 5a  406 depicts native eYFP fluorescence of an intact whole nerve sample from the right DP nerve of 407 Monkey M, while no similar fluorescence of fiber tracts was observed in a control nerve from an 408 uninjected muscle as seen in Figure 5B . Imaris software was used to trace the eYFP expression in 409 Figure 5A and approximate a longitudinal profile of expression. 3D surfaces corresponding to 410 positive eYFP expression were first computed using a built-in local background signal subtraction 411 algorithm and manual removal of noisy features, with the resulting surfaces highlighted in Figure 5C . 412 The volume of these surfaces was then binned as a function of distance along the length of the nerve 413 (200 µm bins), and the resulting longitudinal profile of opsin/eYFP expression was plotted in Figure  414 5D. As seen from Figure 5C and 5D, expression of the viral gene product was not uniform along the 415 nerve as patches of expression would emerge and disappear along the nerve. This finding 416 corroborated the previously described variability in the nerve's sensitivity to optical stimulation 417 (Section 3.1) as well as similar observations in our parallel rodent experiments (see Supplemental 418
Movie 1 (Williams et al., 2016) injection. In the case of monkey P, although expression was evident relatively early at 5 ½ weeks, 445 optical sensitivity had disappeared by the next check at 9 weeks. As we did not test each injected 446 muscle during earlier evaluations in the first two monkeys in order to minimize surgical 447 manipulations at a given site, we cannot rule out that some sites may have demonstrated optical 448 sensitivity at earlier time points similar to Monkey P. Additionally, the focal sensitivity observed 449 along the left DP nerve of monkey M raises the possibility we did not fully expose or probe one of 450 these focal "hotspots" of sensitivity during our earlier assessments while attempting to leave the 451 surrounding tissue grossly intact. Once we more aggressively exposed the DP nerve and its insertion 452 into the TA muscle, stimulation of one of these hotspots likely became more probable. In any case, 453 the time course of expression, as well as differences between species, remains a critical yet poorly 454 understood process. 455
Considerations for chronic optical stimulation 456
Our results also bring forth several considerations for chronic FOS. As one potential application of 457 this gene therapy is to restore volitional control of paralyzed muscle activity through a hybrid 458 optogenetic-BMI, optical nerve stimulation hardware such as chronic LED or fiber optic nerve cuffs 459 must be able to consistently stimulate opsin-labelled axons over a period of years. A potential 460 benefit of using chronically implanted optical nerve cuffs on virally targeted nerves would be the 461 ability to assess the time course of expression without additional surgical procedures. However, the 462 variable expression and sensitivity pattern of ChR2 observed in monkey M in Figure 5 and some of 463 our parallel rat studies (see Supplemental Movie 1 (Williams et al., 2016)) suggests that proper 464 placement of stimulation hardware for either of these applications may be more challenging than 465 initially anticipated. Correct temporal assessment of opsin expression patterns would require blind, 466 accurate placement of nerve cuffs soon after injection over high expression zones on the nerve. 467
Similarly, to provide consistent chronic optical stimulation capabilities in a rehabilitation setting 468 would require 1) an additional evaluation surgery following the virus incubation period to properly 469 place optical cuffs, 2) securing the cuff such that it does not move relative to the hotspot of 470 expression on the nerve, and 3) stability of expression/low turnover at the hotspot. It is possible that 471 the variable optical sensitivity and fluorescent expression observed in this study is due in part to poor 472 expression and trafficking of opsins to the axonal membrane, although another likely contributor may 473 be the immune system through a piecemeal recognition and degradation of opsins by an immune 474 response. Elucidating the underlying cause of this problem could then direct further development of 475 opsins or promoters (Chaffiol et in these studies scale approximately with total body weight, a lack of functional limb movement from 490 optical stimulation in this study could be explained by an insufficient dose of viral particles delivered 491 to muscles with much greater volume compared to prior mouse and rat models. Based on rodent 492 studies, it is possible that doses on the order of 10 14 vp per muscle might be necessary to yield 493 consistent opsin expression that is functional for eliciting limb movements in primates. 494
Virus delivery approaches 495
The differences in viral load as a function body weight across animal models highlights another 496 difficulty in scaling this gene therapy approach up to humans. As the volume of muscle and 497 corresponding zone of neuromuscular junctions targeted for viral uptake increases dramatically from 498 rodent to primate, efficient delivery of viral particles to the entire motor end plate may become both 499 expensive and technically challenging. Our first attempt to address this challenge was to simply 500 increase the volume of viral solution injected with hypertonic saline to be on the same order of 501 magnitude used in rodent studies (~200 µL/kg bodyweight vs 100 µL/kg bodyweight in (Maimon et  502 al., 2017)) with the potential ramifications discussed above. Our second approach was to attempt to 503 localize zones of high neuromuscular junction density near the motor end plate using electrical 504 stimulation. Previous rodent studies have demonstrated that targeting muscle injections along motor 505 endplates greatly enhances motor neuron transduction (Tosolini et al., 2013; Tosolini and Morris, 506 2016) . Targeting of the motor end plate as in these studies requires prior histological mapping of the 507 motor end plate in a given muscle in situ followed by visual alignment of anatomical landmarks in 508 the subject to be injected. Conversely, our approach uses electrophysiological responses to map the 509 end plate and potentially account for anatomical variability between animals. A third injection 510 approach that we employed in Monkey P that may be promising for scaling up injections with animal 511 size was to inject virus directly into the nerve branch of interest. Our experience with this technique 512 has shown that intraneural injections near the insertion of the nerve into the muscle may effectively 513 utilize the nerve sheath to contain and funnel the virus toward the motor end plate as the nerve 514 branches out within the muscle (Williams et al., 2016) . Therefore, virus that does not directly enter 515 nerve axons upon injection but instead resides in the connective tissue perineurium may still be 516 guided back down to the muscle where it may have a greater probability of uptake at neuromuscular 517 junctions. Utilization of nerve injections in this manner could significantly reduce the volume of 518 virus needed for effective motor neuron transduction in larger animals such as the macaque. 519
Intraneural injections at sites more proximal to the spinal cord such as the sciatic nerve do hold the 520 possibility of transducing unwanted sensory neurons. However, injecting the nerve closer to the 521 target muscle would likely minimize unrelated sensory transduction or limit it to proprioceptive 522 fibers that could be utilized for feedback. 523
Viral vector design 524
In addition to the load and route of viral particles delivered to motor nerves, the composition of the 525 viral construct itself holds great potential for improvement of motor nerve transduction. The 526 mechanisms by which AAV vectors undergo uptake at the neuromuscular junction and traffic to the 527 spinal cord are not completely understood, but presumably it is a receptor-mediated process 528 facilitated by domains on the viral capsid which confer tissue tropism to various serotypes. A better 529 fundamental understanding of these uptake and transport processes could inform the design of viral 530 vectors for peripheral motor gene therapies. An alternative approach recently taken by several 531 groups is "directed evolution" or high-throughput screening and selection of recombinant AAV 532 variants for a desired trait (Choudhury et al., 2016; Dalkara et al., 2013; Tervo et al., 2016) . 533
Similarly, the hSyn promoter has been commonly used for peripheral nerve transduction due to its 534 specificity for neural tissues yet relatively strong expression. Using a promoter restricting expression 535 to specific nerve fiber types (e.g. slow/fast fatiguable motor units, proprioceptive fibers, etc.) would 536 enable selective modulation of efferent or afferent activity as well as an approach to artificially 537 specify the recruitment order of motor unit types. However, in general, more specific promoters 538 result in weaker expression in the target tissues, so this tradeoff of nerve optical sensitivity versus 539 fiber type specificity would have to be addressed. 540
Immune Response to AAV 541
AAV6 was chosen as the gene delivery vehicle in this study due to AAV's safety profile and low 542 immunogenicity (Calcedo and Wilson, 2013) as well as its previously demonstrated success in 543 transducing peripheral motor nerves in non-human primates (Towne et al., 2009 Hz for clinical applications (Doucet et al., 2012) . However, due to the previously discussed 563 differences in recruitment order between optical and electrical stimulation, further study is required 564 to elucidate how these optical stimulation parameters translate to functional force production and 565 how to optimize modulation strategies for neuroprosthetic driven movements. 566
The EMG relation to optical stimulation parameters explored here was only characterized for the 567 opsin ChR2. Although its use in this and similar prior studies in rodents as a first line of 568 investigation is warranted by ChR2's well-characterized behavior and consistent expression patterns 569 in a wide array of neural systems, other recently developed opsins may hold properties beneficial to 570 peripheral motor stimulation. Indeed, we injected several muscles in our second monkey with a 571 construct using the opsin Chronos to exploit Chronos's increased sensitivity and faster kinetics to 1) 572 lower the light intensity and consequently power requirements for implantable optical stimulation 573 hardware, and 2) increase the frequency range of pulsed stimulation trains to at least comparable 574 levels used for FES. Recent studies have supported the fast temporal advantages of Chronos over 575
ChR2 in the central auditory pathway (Guo et al., 2015; Hight et al., 2015) . Although this study 576 demonstrated a novel use of Chronos in the motor periphery, the brief period during which we were 577 able to observe its response left us unable to fully examine whether these purported benefits extend to 578 the peripheral motor system. However, preliminary data from our parallel rat studies (Williams et al., 579 2016) suggest that Chronos does have a better frequency response for light stimulus-EMG coupling 580 in the periphery than ChR2 (see Supplemental Figure S2 ). Other opsins which may prove beneficial 581 for peripheral applications include red-shifted variants such as Chrimson (Klapoetke et al., 2014 In summary, the viral transduction and functional expression of opsins for peripheral optical 599 modulation of muscle activity in non-human primates is a step toward efficient reanimation of 600 movement in paralyzed subjects. The introduction of neuromuscular junction targeting for virus 601 injection is a useful technique for increasing the likelihood of virus uptake. In addition, the EMG 602 response characteristics to optical stimulation parameters described here serve as an important base 603 upon which to build future primate studies and FOS algorithms. 604
While the jump from rodent to primate is important in itself, this study also highlights problems due 605 to differences in scale and species that may not have been as pronounced in prior rodent studies. 606
Potential variability in both the timeline and spatial profile of expression, the immune system's 607 probable role in this variability, and effectiveness of the virus as well as light delivery in much larger 608 target muscles/nerves are all challenges that must be addressed before FOS may become a clinically 609 viable approach to restoring lost motor function. 610
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